Skip to main content
COLL
NASDAQ Life Sciences

Collegium Launches $50M Accelerated Share Repurchase at $25.70

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$26.39
Mkt Cap
$836.679M
52W Low
$25.47
52W High
$50.787
52W Position info
3.6% above low
Off High info
48% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

COLL is trading near its 52-week low of $25.47 (3.6% above the low) on elevated volume (2.4× avg).

Summary

Collegium launched a $50M accelerated share repurchase, receiving 1.56M shares at $25.70, as part of its $150M buyback program.


Key Events · Financing and Capital Events · COLL

  • $50M ASR Executed

    Collegium entered an accelerated share repurchase agreement with Jefferies LLC to buy back $50 million of common stock.

  • Initial Share Delivery

    Received 1,556,420 shares at $25.70 per share, representing approximately 80% of expected total repurchases under the ASR.

  • Part of $150M Program

    The ASR is part of the $150 million share repurchase program authorized by the Board in July 2025.

  • Settlement by Q4 2026

    Final number of shares repurchased will be based on volume-weighted average prices during the ASR term, with settlement expected no later than Q4 2026.


Analysis · COLL · Life Sciences

Collegium executed a $50 million accelerated share repurchase with Jefferies, receiving 1.56 million shares immediately at $25.70 — about 80% of the expected total. The buyback is part of the $150 million program authorized in July 2025 and comes as the stock trades near its 52-week low, signaling management's view that shares are undervalued. The ASR reduces share count quickly, supporting EPS, but the final number of shares repurchased depends on the volume-weighted average price over the term, with settlement expected by Q4 2026.

At the time of this filing, COLL was trading at $26.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $836.7M. The 52-week trading range was $25.47 to $50.79. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

COLL - Latest Insights

COLL
Aug 13, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
COLL
Aug 06, 2026, 7:34 AM EDT
Filing Type: 10-Q
Importance Score:
8
COLL
Aug 06, 2026, 7:33 AM EDT
Filing Type: 8-K
Importance Score:
8
COLL
Aug 06, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
COLL
Jun 30, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
7